A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

This study is ongoing, but not recruiting participants.

Study NCT00398710 Information provided by Keryx / AOI Pharmaceuticals, Inc.

First Received: November 9, 2006 Last Updated: April 4, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2009
Estimated Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)